Eli Lilly (LLY) Change in Cash (2009 - 2026)

Eli Lilly (LLY) has reported Change in Cash for 18 consecutive years, with -$2.0 billion the latest figure, recorded in Q1 2026.

• Change in Cash for Q1 2026 came in at -$2.0 billion, down 1034.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 246.14% YoY), and the FY2025 annual result was $4.0 billion, up 790.87% from the prior year.
• Change in Cash was -$2.0 billion for Q1 2026 at Eli Lilly, up from -$2.5 billion in the prior quarter.
• Over five years, Change in Cash peaked at $6.4 billion in Q3 2025 and troughed at -$2.5 billion in Q4 2025.
• Average Change in Cash over 5 years is $86.1 million, with a median of -$101.4 million recorded in 2024.
• Year-over-year, Change in Cash sank 5603.64% in 2023 and jumped 4312.65% in 2025.
• Over 5 years, Change in Cash stood at -$550.4 million in 2022, then soared by 179.61% to $438.2 million in 2023, then sank by 123.14% to -$101.4 million in 2024, then plunged by 2388.66% to -$2.5 billion in 2025, then grew by 21.3% to -$2.0 billion in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$2.0 billion in Q1 2026, -$2.5 billion in Q4 2025, and $6.4 billion in Q3 2025.